Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Singapore Catalist Market  >  TalkMed Group Limited    5G3   SG2G61000003

TALKMED GROUP LIMITED

(5G3)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Singapore Catalist Market
11/20/2020 11/24/2020 11/25/2020 11/26/2020 11/27/2020 Date
0.43 0.45 0.44 0.435 0.435 Last
12400 172200 20000 12000 400 Volume
0.00% +4.65% -2.22% -1.14% 0.00% Change
Financials
Sales 2020 57,1 M 42,7 M 42,7 M
Net income 2020 21,6 M 16,1 M 16,1 M
Net Debt 2020 - - -
P/E ratio 2020 21,8x
Yield 2020 2,30%
Sales 2021 59,9 M 44,8 M 44,8 M
Net income 2021 24,9 M 18,6 M 18,6 M
Net Debt 2021 - - -
P/E ratio 2021 21,8x
Yield 2021 2,30%
Capitalization 573 M 429 M 429 M
Capi. / Sales 2020 10,0x
Capi. / Sales 2021 9,57x
Nbr of Employees -
Free-Float 16,7%
More Financials
Company
TalkMed Group Limited is a Singapore-based investment holding company. The Company's principal activities are the provision of medical oncology services and stem cell transplant services. The Company's segments include Oncology services and Stem cells services. Its doctors provide tertiary healthcare services in the fields of medical oncology, stem cell transplant and palliative care to the oncology patients in the... 
More about the company
All news about TALKMED GROUP LIMITED
11/10FINANCIAL STATEMENTS AND RELATED ANN : Third Quarter Results
PU
05/13GENERAL ANNOUNCEMENT : Minutes of Annual General Meeting (note: this announcemen..
PU
02/17CASH DIVIDEND/ DISTRIBUTION : :Mandatory
PU
2019CHANGE - CHANGE IN CORPORATE INFORMA : :incorporation of subsidiary and restruct..
PU
More news
News in other languages on TALKMED GROUP LIMITED

- No features available -

More news
Chart TALKMED GROUP LIMITED
Duration : Period :
TalkMed Group Limited Technical Analysis Chart | 5G3 | SG2G61000003 | MarketScreener
Technical analysis trends TALKMED GROUP LIMITED
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Average target price 0,49 SGD
Last Close Price 0,44 SGD
Spread / Highest target 12,6%
Spread / Average Target 12,6%
Spread / Lowest Target 12,6%
EPS Revisions
Managers
NameTitle
Peng Tiam Ang Chief Executive Officer & Executive Director
Sitaram Chandra Das Independent Non-Executive Chairman
Kei Siong Khoo Chief Operating Officer & Executive Director
Boon Yong Lee Chief Financial Officer & Co-Secretary
Yih Pin Sitoh Independent Non-Executive Director
Sector and Competitors